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Highland areas where malaria transmission is unstable 
are targets for malaria elimination because transmission 
decreases to low levels during the dry season. In highland 
areas of Kipsamoite and Kapsisiywa, Kenya (population 
≈7,400 persons), annual household indoor residual spray-
ing with a synthetic pyrethroid was performed starting in 
2005, and artemether/lumefantrine was implemented as 
ﬁ   rst-line malaria treatment in October 2006. During April 
2007–March 2008, no microscopy-conﬁ  rmed cases of ma-
laria occurred at the sites. In 4 assessments of asymptom-
atic persons during May 2007–April 2008, a total of <0.3% 
of persons were positive for asexual Plasmodium falciparum 
by microscopy or PCR at any time, and none were positive 
by PCR at the last 2 sample collections. Our ﬁ  ndings show 
that in such areas, interruption and eventual elimination of 
malaria transmission may be achievable with widespread 
annual indoor residual spraying of households and artemisi-
nin combination therapy.
W
idespread implementation of malaria control inter-
ventions such as insecticide-treated bed nets (ITNs) 
and artemisinin combination therapy (ACT) have resulted 
in dramatic reductions of transmission in areas where this 
disease is endemic (1–3). For the ﬁ  rst time since the 1950s, 
the World Health Organization and other organizations 
are promoting malaria eradication (4). In highland areas 
(>1,500 m above sea level) in Africa, malaria transmis-
sion is unstable, with a low incidence of malaria during dry 
seasons (5). These areas may be ideal initial targets for at-
tempting the interruption of malaria transmission. Also in 
these areas, the combination of ACT, which may decrease 
transmission by reducing gametocyte load in infected per-
sons, and annual indoor residual spraying (IRS) with long-
lasting insecticides, which can reduce indoor vector density 
for a prolonged period, could act synergistically to interrupt 
malaria transmission.
We have conducted malaria epidemiology studies in 
the adjoining highland areas of Kipsamoite and Kapsisiywa, 
Nandi Hills District, Kenya, since 2003. Starting in 2005, 
the Ministry of Health of Kenya introduced new interven-
tions to reduce malaria transmission and improve malaria 
treatment in these areas. Interventions introduced included 
IRS, distribution of ITNs to pregnant women and their chil-
dren <5 years of age, and provision of artemether/lumefan-
trine (co-artemether) as ﬁ  rst-line therapy for uncomplicated 
malaria. The present study documents the changes in ma-
laria transmission that occurred during the period of these 
interventions and provides evidence that malaria transmis-
sion was interrupted during April 2007–March 2008.
Methods
Study Site
The study was conducted in the adjacent highland areas 
of Kipsamoite (7 villages) and Kapsisiywa (9 villages) in the 
Nandi Hills District of Kenya. Study site characteristics have 
been described (6). Elevation ranges from 1,829 m to 2,132 
m. In both areas, malaria transmission is unstable. A malaria 
epidemic occurred in Kipsamoite in 2002 (7). Historically, 
Kapsisiywa has had more malaria cases than Kipsamoite, 
likely because its elevation is lower, a swamp surrounds it, 
and it has more areas where water is likely to pool (6).
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Study Population and Recruitment
Persons living in these areas are predominantly Nandi, 
a Kalenjin subtribe. Demographic analysis, malaria sur-
veillance, and collection of weather and vector density 
information were performed in these areas as part of 2 
related studies, a study of malaria early warning systems 
and a study of malaria transmission and immunity. Writ-
ten informed consent for study participation was obtained 
from consenting heads of households in the area for de-
mographic studies and from persons (or parents/guardians 
of persons <15 years of age) for other studies. Ethical ap-
proval for the study was obtained from the Kenya Medical 
Research Institute National Ethical Review Committee and 
the Institutional Review Boards for Human Studies at Case 
Western Reserve University, the Centers for Disease Con-
trol and Prevention, and the University of Minnesota.
Demography and Surveillance for Clinical 
Malaria and Asymptomatic Persons
Demographic surveys of all households were started 
in April 2003 and conducted every 4 to 6 months. Start-
ing in 2005, these surveys included assessments of travel, 
ITN use, and IRS treatment of houses. Clinical malaria 
surveillance was conducted during 2003–2008 Kenyan 
Ministry of Health dispensaries, the only healthcare fa-
cilities within the study area. Free malaria diagnosis and 
treatment were available to all persons with symptoms of 
malaria. Persons with symptoms of malaria (fever, chills, 
severe malaise, headache) who did not have a clear al-
ternative diagnosis by history and physical examination 
were assessed for malaria by microscopic examination of 
blood smears.
Clinical malaria was deﬁ  ned as symptoms of malaria 
and a positive blood smear for Plasmodium falciparum or P. 
malariae. Primary treatment for uncomplicated malaria was 
given according to Kenya Ministry of Health provisions for 
the clinics: sulfadoxine-pyrimethamine (2003–2004), amo-
diaquine (2004–2006), and co-artemether (2006–2008). 
Because of changes in studies, forms, and clinic person-
nel, clinical surveillance was not conducted in January and 
July–November 2006, in Kipsamoite; and July–December 
2005, and January, March, and June–November 2006, in 
Kapsisiywa.
Four surveys for parasitemia in asymptomatic persons 
were conducted during 2007–2008. In May 2007, samples 
were collected from all consenting persons who were liv-
ing on site during the time of collection (5,788 persons). 
In August 2007, samples were collected from 605 per-
sons randomly selected from the overall population for 
active surveillance of malaria. Testing was repeated in 
samples from 577 and 538 of these persons in the cohort 
in November 2007 and April 2008, respectively. PCR was 
performed on 400 randomly selected samples from each 
period and on any sample that was parasite positive by 
microscopy.
Microscopy and PCR
Microscopy testing for Plasmodium species was per-
formed as described (7) by using 2 independent readings 
and a third reading for slides with discordant results. For 
PCR testing, genomic DNA was isolated with a QIAamp 
96 DNA blood kit (QIAGEN Inc., Valencia, CA, USA) 
from dried blood spots collected on Whatman 903 ﬁ  lter pa-
per (Whatman Corporation, Florham Park, NJ, USA). P. 
falciparum infection was detected by nested PCR speciﬁ  c 
for the small subunit RNA gene as described (8). In previ-
ous surveys in these areas, we documented low frequencies 
of P. malariae infection (<1%) and no P. vivax or P. ovale 
infections (7,9) by microscopy and PCR. Thus, we did not 
further test for these infections.
Assessment of Rainfall, Temperature, 
and Indoor Resting Vector Density
Daily rainfall was measured with standard metal rain 
gauges, and daily minimum and maximum temperatures 
were recorded with maximum/minimum mercury ther-
mometers placed in 7 villages in Kipsamoite. Values from 
the 7 villages were averaged.
Household indoor resting density of Anopheles spp. 
was measured in 4 cluster areas at each site; each cluster 
area comprised approximately equal numbers of persons. 
Three index households were randomly selected for each 
cluster, and the index house plus its 4 nearest neighbors 
were sampled. Sixty households in Kipsamoite and 60 
households in Kapsisiywa were sampled every 2 weeks. 
Pyrethrum knockdown captures were conducted by using 
standard methods (10). Anopheles spp. mosquitoes were 
identiﬁ  ed taxonomically, ﬁ  rst in the ﬁ  eld by trained ﬁ  eld 
assistants and then by an entomologist from the Kenya 
Medical Research Institute.
Data Analysis
Annual malaria incidence, rainfall, temperature, and 
vector density during April 2003–March 2004, were used 
as baseline data and compared with data from subsequent 
years beginning in April 2004. Annual malaria incidence 
was compared by using negative binomial regression 
analysis, except for April 2007–March 2008, when it was 
compared by Fisher exact test because no cases occurred 
during that year. For years with missing months of inci-
dence data, malaria incidence in the recorded months was 
compared with incidence in the same months in the refer-
ence year (April 2003–March 2004). For periods when no 
cases were detected, a 1-sided 95% conﬁ  dence interval was 
constructed. Mean daily temperature and mean monthly 
rainfall were compared by using the 2-sample t test. Me-
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dian monthly vector density was compared by using the 
Wilcoxon rank-sum test. All data analysis was conducted 
by using Stata version 10.0 software (Stata Corp., College 
Station, TX, USA).
Results
IRS, ITNs, and Malaria Treatment with 
Co-artemether at Health Centers
The population ranged from 3,250 to 4,253 in Kipsam-
oite and from 3,412 to 3,841 in Kapsisiywa. The Ministry 
of Health ﬁ  rst conducted limited indoor residual spray-
ing in 2005. The number of households sprayed increased 
markedly in 2007 (Table 1). The primary insecticide used 
in both sites was lambda cyhalothrin at a dose of 10–20 
mg/m2.
ITNs were distributed per Ministry of Health policy to 
pregnant women and their children <5 years of age when 
the women came to the health centers for antenatal care. 
A copayment was required in most instances. Short-lasting 
nets treated with α-cypermethrin were provided during 
2005–2006, and long-lasting nets treated with deltamethrin 
or permethrin have been provided since 2006. Persons were 
asked, “Have you slept under a treated bednet regularly 
since the last demography survey?” During 2006–2008, the 
percentage of persons who reported sleeping under an ITN 
decreased from 17.3% to 11.1% in Kipsamoite and from 
27.9% to 15.1% in Kapsisiywa.
Co-artemether became ofﬁ  cial ﬁ  rst-line treatment for 
uncomplicated malaria by Kenyan Ministry of Health pol-
icy in May 2004, but it was not implemented in these sites 
until October 23, 2006 (Kapsisiwya) and February 6, 2007 
(Kipsamoite). Co-artemether was also not widely available 
in local shops or neighboring clinics before these dates.
Malaria and Symptoms Consistent 
with Malaria, 2003–2008
When compared with the April 2003–March 2004 
reference year, malaria incidence in Kipsamoite increased 
in 2004, returned to 2003 levels in 2005, and decreased in 
2006 (Table 2, Figure 1, panel A). In contrast, malaria in-
cidence decreased slightly in Kapsisiywa in 2004 and then 
decreased in 2005 and 2006 (Table 2, Figure 1, panel B). 
Malaria incidence in Kapsisiywa was higher than in Kip-
samoite in 2003 (p<0.001) and 2004 (p = 0.06), but not in 
any other year. At both sites during March 20, 2007–March 
30, 2008, microscopically conﬁ  rmed cases of malaria were 
found among symptomatic persons (Table 2, Figure 1, pan-
els A and B).
Overall clinic attendance, although seasonal and vari-
able, did not decrease during 2007–2008 at either site (Fig-
ure 1, panels C and D). During March 20, 2007–March 30, 
2008, when 0 of 416 symptomatic persons had evidence 
of P. falciparum parasitemia by microscopy (0%, 1-sided 
95% conﬁ   dence interval 0%–0.9%), 17 (7.3%) of 231 
symptomatic persons who provided blood samples for PCR 
testing were positive for P. falciparum. All PCR-positive 
samples were obtained during March–June, 2007, except 
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Table 1. Indoor residual spraying of households in Kipsamoite 
and Kapsisiywa, Kenya, 2005–2007 
Year, area  Months of spraying 
No. households 
sprayed/total (%)  
2005
 Kipsamoite  Apr–May  37/770  (4.8) 
 Kapsisiywa  Apr–Jun 374/713  (52.5) 
2006
 Kipsamoite  Feb–May  119/786  (15.1) 
 Kapsisiywa  Feb–May  327/716  (45.70 
2007
 Kipsamoite  Apr–Jul 545/773  (70.5) 
 Kapsisiywa  Apr–Jun 656/690  (95.1) 
Table 2. Annual cumulative incidence of Plasmodium falciparum  malaria in Kipsamoite and Kapsisiwya, Kenya, April 2003–March 
2008*†
Kipsamoite Kapsisiywa 
Year 
Cumulative
incidence
Incidence ratio
(95% CI)  p value 
Cumulative
incidence
Incidence ratio 
(95% CI)†  p value 
2003 Apr–2004 Mar  23.20 Ref Ref 106.03 Ref Ref
2004 Apr–2005 Mar  42.53 1.83 (1.36–2.47)  <0.001 82.58 0.78 (0.66–0.91)  0.002
2005 Apr–2006 Mar  18.79‡ 0.81 (0.57–1.16)§ 0.229 8.03¶ 0.10 (0.07–0.15)# <0.001
2006 Apr–2007 Mar  9.30** 0.47 (0.30–0.71)†† <0.001 8.99‡‡ 0.19 (0.12–0.27)§§ <0.001
2007 Apr–2008 Mar   0.00 0.00 <0.001 0.00 0.00 <0.001
*CI, confidence interval; Ref, reference. 
†Annual cumulative incidence/1,000 persons was compared by using negative binomial regression, except for 2007–2008, which was compared by using 
Fisher exact test. 
‡Available data were for all months except January 2006.  
§Compared with same months in 2003–2004 (incidence 23.20/1,000). 
¶Available data were for April–June 2005 and February 2006. 
#Compared with same months in 2003–2004 (incidence 79.41/1,000). 
**Available data were for April–June 2006 and December 2006–March 2007. 
††Compared with same months in 2003–2004 (incidence 19.99/1,000). 
‡‡Available data were for April–May 2006 and December 2006–March 2007. 
§§Compared with same months in 2003–2004 (incidence 48.19/1,000). RESEARCH
for 2 samples, which were obtained in December 2007. In 
symptomatic persons, gametocyte prevalence, assessed by 
microscopy, was low in all years (2.8%, 2.9%, 0.8%, 0.8%, 
and 0% in Kipsamoite and 0.4%, 1%, 0%, 0%, and 0% in 
Kapsisiywa during 2003, 2004, 2005, 2006, and 2007, re-
spectively).
Asexual Parasitemia and Gametocytemia 
in Asymptomatic Persons, 2007–2008
In 4 surveys of asymptomatic persons during 2007–
2008, a total of <0.3% were positive for P. falciparum tro-
phozoites or gametocytes by microscopy during any period. 
In the last 2 periods, no person was positive for asexual P. 
falciparum by PCR (Table 3). The person positive for P. 
falciparum trophozoites by microscopy in April 2008 was 
also positive for gametocytes. PCR showed that this person 
did not have an asexual P. falciparum infection.
Changes in Rainfall, Temperature, and 
Vector Density, 2003–2008
During 2003–2008, no consistent pattern of increased 
or decreased temperature was shown, and the average daily 
temperature during 2007–2008, the year in which no malar-
ia cases were documented by microscopy, was most similar 
to that in 2003, the year of highest malaria incidence (Figure 
2, panel A, Table 4). Average monthly rainfall did not dif-
fer between years (Figure 2, panel B, Table 4). A decrease 
in anopheline mosquito density was seen in 2004, before 
any widespread IRS treatment program, but sustained low 
levels of mosquito density were ﬁ  rst seen after IRS treat-
ments (Figure 2, panel C; Table 5). Of 447 anopheline mos-
quitoes caught over this 5-year period, 439 (98.21%) were 
identiﬁ  ed as An. gambiae, 6 (1.34%) were identiﬁ  ed as An. 
funestus, and 2 (0.45%) were not identiﬁ  ed.
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Figure 1. Malaria incidence and number of patients seen at health dispensaries in 2 highland areas of western Kenya, April 2003–March 
2008. A) Monthly incidence of malaria/1,000 persons in Kipsamoite. B) Monthly incidence of malaria/1,000 persons in Kapsisiywa. C) No. 
patients who came to the Kipsamoite health dispensary. D) No. patients who came to the Kapsisiywa health dispensary. Gaps in panels 
A and B indicate that no data were collected during these periods. Arrows indicate when indoor residual spraying was conducted in the 2 
areas.Possible Interruption of Malaria Transmission
Discussion
Implementation of highly effective methods of de-
creasing malaria transmission, including ITNs, IRS, and 
ACT, has led to renewed discussion about global eradi-
cation of malaria (4,11). A major goal in moving toward 
eradicating malaria is interruption or elimination of local 
malaria transmission. The World Health Organization has 
stated that “elimination has been achieved when the ‘pre-
vention of reintroduction’, without local transmission by 
mosquitoes, has been successful for three or more consecu-
tive years” (12). Interruption of local transmission is the 
step before elimination, in which it is documented that local 
transmission of malaria is absent in a previously malaria-
endemic area for a speciﬁ  c period. The present study pro-
vides microscopy evidence of interruption of local malaria 
transmission in 2 adjacent highland areas of unstable trans-
mission. Malaria could recur in these areas, and it is unclear 
precisely how much speciﬁ  c factors (e.g., IRS, ACT, and 
changes in rainfall and temperature) affected malaria trans-
mission and incidence. Overall, however, data support the 
idea that in unstable transmission settings, combining regu-
lar, widespread IRS campaigns and use of ACT as ﬁ  rst-line 
antimalarial treatment has the potential to interrupt local 
malaria transmission.
IRS probably played a major role in reducing malaria 
transmission in these areas for several reasons. First, sus-
tained decreases in indoor resting Anopheles spp. mosquito 
density were seen after the IRS campaigns. Second, in 
both sites, malaria incidence decreased only after IRS was 
widely applied. In Kipsamoite, no large reduction in ma-
laria incidence was seen until 2007, when spraying covered 
>70% of households. In Kapsisiywa, ≈50% of households 
were sprayed in 2005 and 2006, and a large decrease in ma-
laria incidence was observed in both years. In 2007, after 
>90% of households were sprayed, malaria transmission 
was interrupted for the subsequent year. Third, in contrast 
to IRS, 2 factors that could affect vector density and there-
fore malaria incidence, rainfall and temperature, showed 
no clear relationship with either vector density or malaria 
incidence.
A reduction in vector density was seen in both sites in 
2003 before the IRS campaigns. Potential reasons for this 
reduction include an unusual decrease in temperature dur-
ing July–September 2003 (Figure 2). This decrease in tem-
perature coincided with the ﬁ  rst decrease in vector density; 
another possible reason for the decrease was pyrethrum 
spray catch testing of anopheline vectors conducted by our 
team, which started in April 2003.  Although spraying with 
short-term insecticide does not usually affect vector density 
in areas of high transmission, spraying of approximately 
one sixth of all households every 2 weeks may have had an 
effect on the adult vector population, which led to a smaller 
breeding pool and lower overall vector density in this area 
of low transmission. The decrease in malaria incidence in 
Kipsamoite in 2005, after only 15% of households were 
sprayed, may in part reﬂ  ect the effects of greater spraying 
in neighboring Kapsisiywa. The decrease may also reﬂ  ect 
the combined effect of partial coverage with ITNs and ad-
ditional coverage by IRS. Reduction of incidence in Kip-
samoite in 2005 was not caused by concentrated spraying in 
areas of malaria clustering (5) because spraying was near-
ly absent in these areas. Reductions in malaria incidence 
were seen in Kapsisiywa in 2005–2006 after spraying of 
40%–50% of households, but the small peak in incidence 
seen subsequently in these 2 years, but not 2007 (Figure 1), 
suggests that for interruption, a higher percentage of house-
holds (>70%) must be sprayed.
Treatment of malaria patients with co-artemether re-
duces gametocyte carriage and density in children and 
makes them less infectious to mosquitoes than treatment 
with sulfadoxine-pyrimethamine plus chloroquine (13). 
The effect of co-artemether on gametocytes may have 
been synergistic with the effect of widespread IRS on the 
Anopheles spp. vector in reducing malaria transmission. In 
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Table 3. Prevalence of Plasmodium falciparum parasitemia by microscopy and PCR in asymptomatic persons in Kipsamoite and 
Kapsisiywa, Kenya, May 2007–April 2008 
Characteristic 2007 May   2007 Aug 2007 Nov 2008 Apr
Microscopy 
 No.  P. falciparum positive 14* 0 0 1
 No.  tested  5,788 605 577 538
 %  P. falciparum positive  0.24 0 0 0.19
Gametocytes 
 No.  positive  5† 0 0 1
 No.  tested  5,788 605 577 538
 %  positive  0.09 0 0 0.19
PCR
 No.  P. falciparum positive  1 1 0 0
 No.  tested  414 400 400 401
% P. falciparum positive  0.24 0.25 0 0
*Twelve persons who tested positive by microscopy were from Kipsamoite and 2 were from Kapsisiywa. 
†Four persons who tested positive by gametocyte were from Kipsamoite and 1 was from Kapsisiywa. RESEARCH
symptomatic persons, gametocyte prevalence was always 
low, and it decreased before introduction of co-artemether, 
but it did not decrease to undetectable levels in Kipsamoite 
until after introduction of co-artemether. Among asymp-
tomatic persons, studies during 1999–2002 generally dem-
onstrated higher gametocyte prevalence (0%–5.7%) (7). 
Lower prevalence among asymptomatic persons in the cur-
rent study (0%–0.2% during May 2007–April 2008) could 
reﬂ  ect effects of co-artemether on gametocyte prevalence 
after introduction of co-artemether in late 2006–early 2007, 
but without interim data from 2002–2006, an association 
cannot be clearly demonstrated. As with IRS, however, ab-
sence of microscopy-positive malaria cases occurred only 
after introduction of co-artemether. Because co-artemether 
was ﬁ  rst used during a time of low transmission of malaria, 
the contribution of ACT to the absence of malaria incidence 
could not be quantiﬁ  ed in the present study. However, a 
much larger study in South Africa in which IRS treatment 
and ACT treatment of persons with clinical malaria were 
introduced sequentially demonstrated an additional reduc-
tion of malaria incidence after introduction of ACT (14) 
and this supports the idea of synergy between these 2 in-
terventions.
Although ITNs are the preferred intervention for pre-
venting malaria-related illness and death in areas of high 
transmission (1,15,16), ITNs probably did not play a major 
role in interrupting malaria transmission in the highland ar-
eas we studied. ITN coverage never exceeded 30% in either 
area, and use actually decreased over the study period. In 
areas of unstable transmission, IRS treatment once a year 
is likely to be easier, more effective, and more accepted 
than ITNs. The Roll Back Malaria program currently rec-
ommends IRS as the preferred method of reducing malaria 
in areas of low transmission (17); our study supports this 
recommendation.
Insecticide treatment using IRS is not without prob-
lems; chief among them is potential development of resis-
tance to the insecticide. Lambda-cyhalothrin, the insecti-
cide used for IRS in these areas by the Kenyan Ministry of 
Health, was used in Mozambique for IRS starting in 1993, 
but resistance developed to such an extent that lambda cy-
halothrin was replaced by bendiocarb in 2000. By 2006, 
however, lambda cyhalothrin resistance had decreased in 
many areas (18). In a recent study in nearby areas of west-
ern Kenya, no phenotypic resistance to pyrethroid insecti-
cides was seen, but 27% of anophelines carried the knock-
down resistance (kdr) mutation associated with increased 
resistance to pyrethroids (19). Assessment for insecticide 
resistance in the highland areas of the present study will 
enable better policy decisions to be made about continued 
use of lambda cyhalothrin, use of alternatives such as ben-
diocarb or DDT, or cycling of insecticides when certain re-
sistance thresholds are reached for a particular insecticide. 
P.  falciparum resistance to sulfadoxine-pyrimethamine 
was present in 27% of infections in western Kenya as early 
1922  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009
Figure 2. Temperature, rainfall, and vector density in 2 highland 
areas of western Kenya, April 2003–May 2008. A) Average daily 
temperature (°C) in Kipsamoite. B) Monthly rainfall (mm) in 
Kipsamoite. C) Median biweekly vector density (no. Anopheles spp. 
mosquitoes/household) in Kapsisiywa (red line) and Kipsamoite 
(black line). Gaps in panels indicate that no data were collected 
during these periods. Arrows indicate times when indoor residual 
spraying was conducted.Possible Interruption of Malaria Transmission
as 1999 (20). Resistance to co-artemether has not yet been 
documented in Kenya, but development of resistance to 
components of artemether/lumefantrine in nearby popula-
tions with higher levels of transmission would also pose a 
threat to this highland population. Monitoring of drug resis-
tance to ACT in all areas in which malaria is endemic will 
be critical for sustaining reduction of malaria incidence in 
sub-Saharan Africa.
Limitations of our study include missing monthly ma-
laria incidence data among symptomatic persons during 
2005–2006, the observational nature of the study, and the 
possibility that lack of parasitemia by microscopy and PCR 
in symptomatic and asymptomatic persons was caused by 
seasonal variation common in highland areas (21) and not 
by interruption of local transmission. However, 3 pieces of 
evidence from studies of asymptomatic and symptomatic 
persons support interruption of local transmission rather 
than seasonal variation. First, no parasitemia was seen in 
2 successive microscopy and PCR surveys of asymptom-
atic persons, whereas in 5 earlier surveys of asymptomatic 
persons in Kipsamoite, the area of lower transmission, the 
frequency of infected persons was never zero (range 5.9%–
14.5% by PCR) (7). Second, over 7 years of clinic surveil-
lance of symptomatic persons in Kipsamoite and 5 years in 
Kapsisiywa, there was never a >4-month period in which 
there were no microscopy-positive cases of P. falciparum 
before March 2007. Thus, even with seasonal variation, a 
year with no microscopy-positive cases in these areas is 
unprecedented. Third, absence of gametocytemia by mi-
croscopy was documented among asymptomatic persons in 
2 of 4 assessments and among symptomatic persons for a 
year (April 2007–March 2008), which suggested that the 
potential for local transmission was low or absent.
Because reverse transcription–PCR methods for de-
tection of gametocytes have documented higher rates of 
gametocyte infection than microscopy (22,23), we are de-
veloping this testing method in our laboratory to conﬁ  rm 
the absence of gametocytemia in the most recent samples 
from study participants. The presence of asexual P. falci-
parum infection by PCR in 15 symptomatic persons during 
April–June 2007 could reﬂ  ect prolonged detection by this 
more sensitive method. The presence of only 2 PCR-pos-
itive cases in a 9-month period (July 2007–March 2008) 
suggests that malaria transmission was either interrupted, 
if these cases were caused by patients’ travel, or reduced to 
almost undetectable levels.
Sustained elimination of local malaria transmission in 
these areas will require ongoing surveillance of malaria in-
cidence, anopheline vector density, and anopheline insec-
ticide resistance, and correctly timed IRS campaigns with 
broad coverage of the area (24). The longer populations 
at these sites are unexposed to malaria, the more suscep-
tible they are to malaria epidemics, which could occur if 
an increase in vector density occurs in conjunction with the 
arrival of infected persons or mosquitoes from an area of 
higher transmission of malaria. Because travel is increas-
ingly frequent, true elimination of malaria in this and other 
highland areas will require reduction and eventual elimina-
tion of malaria in surrounding areas. Co-artemether must be 
consistently available to treat any infected and symptomatic 
travelers or immigrants to the area. Finally, as malaria cas-
es decrease, microscopists will need to receive training to 
remain proﬁ  cient in detection of malaria in blood smears.
In summary, this study demonstrates pronounced re-
duction and possible interruption of malaria transmission 
in 2 highland areas of Kenya for a 1-year period and pro-
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Table 4. Average monthly rainfall and average daily temperature for Kipsamoite, Kenya, April 2003–March 2008* 
Year  Mean (SD) monthly total rainfall, mm† p value  Mean (SD) daily temperature, °C† p value 
2003 Apr–2004 Mar  132.8 (83.6)  Ref 18.5 (0.9)  Ref
2004 Apr–2005 Mar  101.4 (48.9)  0.274 18.7 (0.6)  0.510
2005 Apr–2006 Mar  119.2 (97.6)  0.717 18.8 (0.6)  0.346
2006 Apr–2007 Mar  130.5 (76.7)  0.957 17.8 (0.6)  0.039
2007 Apr–2008 Mar   105.2 (81.6)  0.422 18.8 (0.6)  0.352
*Ref, reference.  
†Means were compared by using the 2-sample t test. 
Table 5. Median monthly Anopheles spp. mosquitoes per household in Kipsamoite and Kapsisiwya, Kenya, April 2003–March 2008* 
Kipsamoite Kapsisiywa 
Year 
Median monthly Anopheles spp. 
mosquito density (IQR)† p value 
Median monthly Anopheles spp. 
mosquito density (IQR)† p value 
2003 Apr–2004 Mar  0.079 (0.100)  Ref 0.091 (0.112)  Ref
2004 Apr–2005 Mar  0.014 (0.033)  0.003 0.023 (0.031)  0.005
2005 Apr–2006 Mar  0.000 (0.007)  <0.001 0.009 (0.012)  <0.001
2006 Apr–2007 Mar  0.000 (0.004)  <0.001 0.006 (0.018)  0.002
2007 Apr–2008 Mar   0.000 (0.000)  <0.001 0.000 (0.000)  0.002
*IQR, interquartile range (difference between 75th and 25th percentile values); ref, reference. 
†Median vector density was compared by using the Wilcoxon rank-sum test. RESEARCH
vides evidence that interruption of transmission was related 
to widespread annual IRS insecticide treatment and use of 
ACT as ﬁ  rst-line treatment for uncomplicated malaria. Al-
though both areas remain at risk for recurrence of malaria 
epidemics, our study provides evidence that interruption 
and eventual elimination of malaria in areas of unstable 
transmission may be achievable.
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